goralatide has been researched along with Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bignon, J; Garcia-Alvarez, MC; Kusinski, M; Kuzdak, K; Liu, JM; Riches, A; Wdzieczak-Bakala, J | 1 |
Abali, H; Engin, H; Erman, M; Güllü, IH; Haznedaroğlu, IC; Tekuzman, G | 1 |
Carde, P; Frindel, E; Tubiana, M | 1 |
Comte, L; Lorgeot, V; Praloran, V; Roullet, B; Tubiana, N; Volkov, L | 1 |
2 review(s) available for goralatide and Neoplasms
Article | Year |
---|---|
Overexpression of the natural tetrapeptide acetyl-N-ser-asp-lys-pro derived from thymosin beta4 in neoplastic diseases.
Topics: Animals; Biochemical Phenomena; Dipeptides; Mice; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Prolyl Oligopeptidases; Serine Endopeptidases; Thymosin | 2010 |
Ways of minimising hematopoietic damage induced by radiation and cytostatic drugs--the possible role of inhibitors.
Topics: Animals; Antineoplastic Agents; Hematopoiesis; Hematopoietic Stem Cells; Humans; Mice; Neoplasms; Oligopeptides; Radiotherapy | 1993 |
2 other study(ies) available for goralatide and Neoplasms
Article | Year |
---|---|
Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Topics: Angiogenesis Inhibitors; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Platelets; Carcinoma, Lewis Lung; Drug Evaluation, Preclinical; Endothelial Growth Factors; Hematopoiesis; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Matrix Metalloproteinase Inhibitors; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms; Oligopeptides; Platelet Activation; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
AcSDKP plasma concentrations in patients with solid tumours: comparison of two chemotherapeutic regimens.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Female; Fluorouracil; Growth Inhibitors; Humans; Male; Middle Aged; Neoplasms; Oligopeptides | 1997 |